Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Microsoft brings machine learning to genetics collaboration

Will work with Adaptive Biotechnologies on the human immune system

Genetic sequencing

Microsoft has teamed up with Seattle-based sequencing company Adaptive Biotechnologies to map the genetics of the human immune system.

The work aims to aid the early detection of diseases, particularly cancer, allowing them to be more effectively treated.

The IT giant will bring machine learning and cloud computing capabilities, with Adaptive contributing its immune sequencing technologies.

The deal, which will see Microsoft invest in Adaptive, falls within the firm’s Healthcare NExT initiative which was launched last year to accelerate healthcare innovation by applying artificial intelligence and cloud computing.

Peter Lee, corporate VP, AI and research at Microsoft, said: “We are very excited and inspired by our collaboration with Adaptive Biotechnologies, as it clearly advances our mission to use cloud and AI technologies to transform healthcare and improve the lives of people around the world.

The two companies hope to translate the immune system’s genetic code into simple blood-based diagnostics that can be made broadly accessible to people around the world.

Chad Robins, Adaptive’s president, CEO and co-founder, said: “Some conditions like cancer or autoimmune disorders can be difficult to diagnose, but this universal map of the immune system will enable earlier and more accurate diagnosis of disease, potentially helping physicians to connect the dots to understand the relationship between disease states and eventually lead to a better understanding of overall human health.”

31st January 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics